Benefits and risks assessment of simvastatin in familial hypercholesterolaemia

Author： Alonso Rodrigo   Mata Nelva   Mata Pedro  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.4, Iss.2, 2005-03, pp. : 171-181

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Benefits and Risks of Simvastatin in Patients with Familial Hypercholesterolaemia

By Mata P.  

Drug Safety, Vol. 26, Iss. 11, 2003-01 ,pp. : 769-786

Adis International

Access to resources Recommend Favorite

Efficacy, Safety and Tolerability of Simvastatin in Children with Familial Hypercholesterolaemia: Rationale, Design and Baseline Characteristics

By Dejongh S.  

Clinical Drug Investigation, Vol. 22, Iss. 8, 2002-08 ,pp. : 533-540

Adis International

Access to resources Recommend Favorite

Pravastatin for children with familial hypercholesterolaemia

By  

Inpharma, Vol. 1, Iss. 1448, 2004-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

PGD and familial hypercholesterolaemia

By  

Reproductive BioMedicine Online, Vol. 16, Iss. 2, 2008-02 ,pp. : 307-307

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Addition of HRT to simvastatin beneficial in hypercholesterolaemia

By  

Inpharma, Vol. 1, Iss. 1227, 2000-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite